The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Pharmacology, Biochemistry, and Behavior
Richard De La GarzaThomas F Newton

Abstract

A human laboratory model of intravenous methamphetamine self-administration may facilitate study of putative treatments for methamphetamine addiction. We conducted a double-blind, placebo-controlled, between groups investigation of the acetylcholinesterase (AChE) inhibitor rivastigmine in non-treatment-seeking volunteers who met criteria for methamphetamine abuse or dependence. Safety and subjective effects data derived from days 1-10 of this protocol are described in a separate publication. In this report, we describe self-administration outcomes in participants randomized to treatment with rivastigmine (0 mg, N=7; 1.5 mg, N=6; 3 mg, N=9); data that were collected on days 11-15 of the inpatient protocol. On day 11, participants sampled two infusions of methamphetamine (0 and 30 mg, i.v.). On days 12-15, participants made ten choices each day to receive an infusion of either methamphetamine (3 mg, IV) or saline or a monetary alternative ($0.05-$16). The study design allowed for evaluation of differences in behavior on days in which infusions were performed by the physician (experimenter-administered) versus by the participant using a PCA pump (self-administered), and when monetary alternatives were presented in either ascending...Continue Reading

References

Nov 1, 1984·Pharmacology, Biochemistry, and Behavior·W L WoolvertonC E Johanson
Jan 1, 1980·Psychopharmacology·C E Johanson, E H Uhlenhuth
Feb 1, 1981·Pharmacology, Biochemistry, and Behavior·C E Johanson, E H Uhlenhuth
Aug 1, 1997·Psychopharmacology·A S WardR W Foltin
Dec 2, 1998·Behavioural Pharmacology·A S WardR W Foltin
Aug 24, 1999·The European Journal of Neuroscience·V DerocheP V Piazza
Aug 25, 2000·Psychopharmacology·S L WalshG E Bigelow
Jul 10, 2001·Psychopharmacology·S D ComerM W Fischman
Aug 21, 2001·Psychopharmacology·C L HartM W Fischman
May 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Takatoshi HikidaShigetada Nakanishi
Jul 2, 2003·The American Journal of Psychiatry·Roger D WeissKarla Moras
Jul 16, 2003·Clinical Therapeutics·Bradley R WilliamsMark A Gill
Sep 25, 2003·British Journal of Pharmacology·Yaping PanXiaoliang Wang
Apr 16, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kusnandar AnggadiredjaTsuneyuki Yamamoto
Feb 24, 2005·Psychopharmacology·Atapol SughondhabiromRobert T Malison
Aug 23, 2005·Pharmacology, Biochemistry, and Behavior·Thomas F NewtonLiam Nestor
Sep 16, 2005·Psychopharmacology·Kenneth A PerkinsCaryn Lerman
Sep 16, 2005·Psychopharmacology·Thomas F NewtonRoberta Kahn
Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas F NewtonRoberta Kahn
Jan 13, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret HaneyRichard W Foltin
Jan 18, 2006·Pharmacology, Biochemistry, and Behavior·Thomas F NewtonAhmed Elkashef
Mar 23, 2006·Psychopharmacology·Osamu KitamuraLuigi Pulvirenti
May 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Takato HiranitaTsuneyuki Yamamoto
Nov 23, 2006·Pharmacology, Biochemistry, and Behavior·Kelly J ClemensIain S McGregor
Jun 22, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ahmed M ElkashefDennis Weis

❮ Previous
Next ❯

Citations

Sep 23, 2008·Current Psychiatry Reports·Iván D Montoya, Frank Vocci
Dec 24, 2008·The Journal of Pharmacology and Experimental Therapeutics·Rajkumar J SevakCraig R Rush
Oct 22, 2013·Current Psychiatry Reports·Colin N Haile, Thomas R Kosten
May 12, 2011·Pharmacology, Biochemistry, and Behavior·Kathleen T BradyBryan K Tolliver
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence
Oct 20, 2009·Drug and Alcohol Dependence·Kenneth GrasingCherilyn DeSouza
Apr 27, 2013·Drug and Alcohol Review·Matthew BrensilverSteven Shoptaw
Jun 23, 2010·British Journal of Clinical Pharmacology·Laurent KarilaSteven L Batki
Apr 15, 2014·The American Journal on Addictions·Hong-Qiang SunThomas R Kosten
Mar 29, 2016·European Journal of Pharmacology·Dan-Ni CaoJin Li
Sep 14, 2015·The International Journal of Neuropsychopharmacology·Richard De La GarzaDaisy G Y Thompson-Lake
Apr 3, 2012·Physiology & Behavior·Nicole M Avena, Pedro V Rada
Nov 19, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·James J MahoneyRichard De La Garza
Jan 11, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·R De La GarzaA Aziziyeh
Jan 8, 2014·The International Journal of Neuropsychopharmacology·Christopher D VerricoRichard De La Garza
Jul 28, 2016·Neuroscience and Biobehavioral Reviews·Aurelien BernheimCarmela M Reichel
Aug 16, 2016·Radiation Protection Dosimetry·M M HillerM B Bellamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
Richard De La GarzaA Aziziyeh
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Mark J Williams, Bryon Adinoff
© 2021 Meta ULC. All rights reserved